At a glance
- Originator Novo Nordisk
- Class Anti-ischaemics; Antidementias; Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Neurological disorders
Most Recent Events
- 30 Jan 1997 No-Development-Reported for Epilepsy in Denmark (Unknown route)
- 30 Jan 1997 No-Development-Reported for Neurological disorders in Denmark (Unknown route)
- 09 Dec 1996 Preclinical development for Neurological disorders in Denmark (Unknown route)